AI Verdict
KNSA has stronger fundamentals based on our AI analysis.
KNTK vs KNSA Fundamental Comparison
| Metric | KNTK | KNSA |
|---|---|---|
| Revenue | $1.8B | $677.6M |
| Net Income | $178.3M | $59.0M |
| Net Margin | 10.1% | 8.7% |
| ROE | N/A | 10.4% |
| ROA | 2.5% | 7.7% |
| Current Ratio | 0.69x | 3.79x |
| Debt/Equity | N/A | 0.00x |
| EPS | $2.63 | $0.75 |
Green = Better metric | Red = Weaker metric
You Might Also Compare
KNTK vs KNSA: Frequently Asked Questions
Is KNTK or KNSA a better buy in 2026?
Based on dual AI fundamental analysis (Claude and ChatGPT), KNSA has stronger fundamentals. KNTK is rated SELL (85% confidence) while KNSA is rated HOLD (68% confidence). This is not investment advice.
How does KNTK compare to KNSA fundamentally?
Kinetik Holdings Inc. has ROE of N/A vs Kiniksa Pharmaceuticals International, plc's 10.4%. Net margins are 10.1% vs 8.7% respectively.
Which stock pays higher dividends, KNTK or KNSA?
KNTK has a dividend yield of N/A or no dividend while KNSA has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.
Should I invest in KNTK or KNSA for long term?
For long-term investing, consider that KNTK has SELL rating with 85% confidence, while KNSA has HOLD rating with 68% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.
What do the AI models say about KNTK vs KNSA?
Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For KNTK vs KNSA, the AI consensus favors KNSA based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.